WEBINAR DETAILS

About 40 percent of Americans are obese, and the U.S. is well on its way to reaching a 50 percent obesity rate by 2030. The rising rate of obesity continues to pull up rates of type 2 diabetes, and rising rates of type 2 diabetes may well reverse hard fought gains in cardiovascular health Americans have achieved over several decades.

Prevention and treatment of both obesity and type 2 diabetes remain an urgent public health priority, and a critical priority for the population health management the U.S. health care system is counting upon to achieve sustainable rates of health care spending. In 2019 NEHI convened a panel of key opinion leaders among patient advocates, clinicians, payment experts and biopharma leaders to reassess priorities for action. A new NEHI policy brief enumerates several recommendations for action.

Please join us for an in-depth conversation with two of our leading key opinion leaders: Dr. Angela Fitch of Massachusetts General Hospital, and Dr. Robert Gabbay of the Joslin Diabetes Center.

Angela Fitch, MD, FACP, FOMA is the Associate Director of the Massachusetts General Hospital Weight Center and a member of the Harvard Medical School faculty. Dr. Fitch was the Obesity Medicine Association’s 2017 Clinician of the Year, and currently serves as the Association’s Vice President.

Robert Gabbay, MD, FACP is the Chief Medical Officer and Senior Vice President at the Joslin Diabetes Center, Associate Professor of Medicine at Harvard Medical School, and editor-in-chief of Evidence-based Diabetes Management.

For more information, please contact Tom Hubbard at thubbard@nehi.net.